Search Results

PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.

Panel Discussion 

• How can technology improve the lifestyle choices we make and how productive we are at work over time?  
• As wearables move from measuring physical data to measuring brain health, how can we “listen” to our bodies to minimize stress, and avoid lost productivity?
• What nutritional technologies will enable individuals and companies to make the right dietary decisions for healthier and happier lives?
• What role do companies play in furthering these changes?

Panelists: 

• Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health
• Matthew Decker, Global Technical Leader - Comfort and Biophysics Group, W.L. Gore & Associates
• David T. Thibodeau, Managing Director, Wellvest Capital
• Josh Sarmir, Co-Founder & CEO, SplitSage

Moderator: Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP

Alec Shkolnik, CoFounder and CEO, LiquidPiston

Steven Leeb, Professor of Mechanical and Electrical Engineering and Computer Science, MIT Department of Electrical Engineering and Computer Science

Scalable production of RNA for agriculture
  Andrey Zarur, Cofounder & CEO, GreenLight Biosciences
Potassium fertilizer innovation
  Philip Wender, Managing Director, Advanced Potash Technologies 
Chemiresistive gas sensing for food safety
  Merry Smith, Senior Scientist, C2Sense
Novel dehumidifying material for indoor farms
  Sorin Grama, Cofounder, Transaera 
Probiotics for plants 
  Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]

David Shrier, CEO & founder, Distilled Identity

Andrea Adamo, Founder & CEO, Zaiput Flow Technologies

Synthetic Biology Workshop 2017 - Panel Discussion

Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.

Hilton Pryce Lewis, Co-founder, President and CEO, GVD Corporation